Ship in Europe, Find out rates!
Chewable tablets is an antacid-reducing intestinal gas drug based on Magnesium Hydroxide, Aluminum Oxide Hydrate and Dimethicone .
Maalox Plus Chewable Tablets is an adjuvant in gastric hyperacidity and hyperacidity dyspepsia even in the presence of meteorism. It is used in the symptomatic treatment of heartburn and gastric pain and in esophagitis. It is an adjuvant in the treatment of gastroduodenal ulcer.
Always take this medicine exactly as described in this leaflet or as directed by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist. Do not exceed the indicated doses unless advised by your doctor.
The recommended dose in adults and adolescents over 18 years of age is: 2-4 tablets 4 times a day, to be taken 20-60 minutes after meals and at bedtime.
Chew or suck the tablets well. You may swallow water or milk after taking this medicine.
In case of accidental ingestion / intake of an excessive dose of this medicine, consult your doctor immediately or go to the nearest hospital. If you take high doses of this medicine you may experience:
Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Do not use Maalox Plus:
Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop taking Maalox Plus and contact your doctor or nearest hospital immediately if you experience: difficulty in breathing or swallowing, swelling of the face, hands and feet, eyes, lips and / or tongue, skin rashes, itching, hives and dizziness, as these can be symptoms of severe allergic reactions (angioedema and anaphylactic reaction). The following side effects may occur with the use of this medicine:
Uncommon (may affect up to 1 in 100 people): - constipation (constipation) or diarrhea.
Frequency not known (frequency cannot be estimated from the available data): - excessive reaction of the body to foreign substances (hypersensitivity reaction, even severe), appearance of swelling on the skin that cause itching (urticaria) and itching; - changes in the levels of magnesium, aluminum and phosphate in the blood which can cause bone problems.
The medicine should only be used when needed, under the direct supervision of the doctor, after evaluating the expected benefit to the mother in relation to the possible risk to the fetus or infant.
Due to limited maternal absorption when taken according to the indicated dosage regimen, aluminum hydroxide and its combinations with magnesium salts are considered compatible with breastfeeding.
Aluminum hydroxide can cause constipation and an overdose of magnesium salts can cause hypomotility of the intestine; high doses of this medicine may cause or aggravate intestinal obstruction and ileus in patients at higher risk, such as those with renal impairment, with underlying constipation, with impaired bowel motility, in children (0 to 24 months) , or elderly.
Aluminum hydroxide is not well absorbed from the gastrointestinal tract, and systemic effects are therefore rare in patients with normal renal function. However, excessive doses or long-term use, or even normal doses in patients with low phosphorus diets or children (0 to 24 months), can lead to phosphate elimination (due to an aluminum-phosphate bond) accompanied by an increase in bone resorption and hypercalciuria with risk of osteomalacia. It is advisable to consult your doctor in case of long-term use or in patients at risk of hypophosphataemia.
In patients with renal impairment, plasma levels of aluminum and magnesium tend to increase causing hyperalluminaemia and hypermagnesaemia, respectively. In these patients, long exposures to high doses of aluminum and magnesium salts can lead to encephalopathies, dementia, microcytic anemia or worsening of dialysis osteomalacia. Aluminum hydroxide may not be safe in patients with porphyria undergoing hemodialysis.
In the presence of severe forms of renal insufficiency it is recommended to take the product under the direct supervision of a doctor. Prolonged use of the medicinal product should be avoided in these patients. Maalox tablets contain sucrose: this should be taken into account in case of diabetes or low-calorie diets. Due to the presence of sucrose, patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose isomaltase deficiency should not take chewable Maalox. Maalox Plus Chewable Tablets contains parahydroxybenzoates (methyl and propyl parahydroxybenzoate) which can cause allergic reactions (possibly delayed type).
Due to the presence of sorbitol both in the tablets and in the, patients with rare hereditary problems of fructose intolerance should not take Maalox.
Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored.
Warning : do not use the medicine after the expiry date indicated on the package.
Each Maalox Plus chewable tablet contains:
Magnesium hydroxide 200 mg, aluminum oxide, hydrate 200 mg, dimethicone 25 mg
Corn starch, citric acid, pregelatinised starch, glucose, mannitol, sucrose, sorbitol, non crystallizable liquid sorbitol, talc, magnesium stearate, sodium saccharin, lemon flavor, Swiss cream flavor, E 172.
Destination | Cost | Detail |
---|---|---|
Italy | €5,90* | 24/72H |
Austria, France, Germany, Slovenia | € 13* | 3 days |
Belgium, Luxembourg, Portugal, Netherlands, Spain | € 14* | 4 days |
Bulgary, Cechia, Hungary, Poland, Romania, Slovakia | € 19* | 5 days |
Denmark, Estonia, Finland, Ireland, Lithuania, Latvia ,Sweden | € 22* | 5 days |
United Kingdom, Switzerland, Greece | € 30* | 7 days |
Canada, USA | € 40 | 7 Days |